The Asia Pacific Magnetoencephalography Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).
MEG can precisely localize epileptic activity more precisely than any other noninvasive modality can, and it does so without the smearing and blurring that might impair an electroencephalogram (EEG). MEG has an intrinsically high resolution since it utilizes many sensors and is not affected by the skull or scalp in any way. Researchers can localize the neuronal activity to a particular sublobar region, often to a single gyrus or sulcus, when researchers combine MEG with the high-resolution anatomic pictures acquired by MRI. This allows us to pinpoint the precise location of the activity.
MEG helps patients with epilepsy locate the source of their epileptic discharges, and it does so without requiring the placement of electrodes within the patient's skull. When it is necessary to implant intracranial electrodes, magnetic resonance imaging (MEG) may assist in better planning the precise location of the implantation.
MEG technology gives patients undergoing neurosurgery access to helpful information for presurgical mapping in a method that does not involve any intrusive procedures. In addition, MEG technology makes it possible to combine structural and functional information, obtaining high spatial and temporal resolution in the process. This is a combination not presently offered by any other method of researching the brain.
The market for medical equipment in Japan is still significantly reliant on imports, particularly for more technologically advanced medical gadgets. As a result of Japan's rapidly aging demographic profile, there is likely to be a rise in the need for cutting-edge medical technology. Seniors in Japan who have been generally successful throughout their lives have increasingly lofty expectations for the quality of life they will enjoy in their old years. Therefore, there would be widespread acceptance of advances such as magnetoencephalography throughout the country, which would assist the expansion of regional markets.
The China market dominated the Asia Pacific Magnetoencephalography Market by Country in 2021; thereby, achieving a market value of $27,797.6 Thousands by 2028. The Japan market is registering a CAGR of 5% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 6.3% during (2022 - 2028).
Based on Application, the market is segmented into Clinical and Research. Based on Clinical Type, the market is segmented into Epilepsy, Dementia, Autism, Stroke, Multiple Sclerosis, Schizophrenia and Others. Based on End-use, the market is segmented into Hospitals, Academic & Research Institutes and Imaging centres. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Compumedics Limited, Ricoh Company, Ltd, FieldLine, Inc., MEGIN OY, CTF MEG Neuro Innovations, Inc. and Cerca Magnetics Limited
MEG can precisely localize epileptic activity more precisely than any other noninvasive modality can, and it does so without the smearing and blurring that might impair an electroencephalogram (EEG). MEG has an intrinsically high resolution since it utilizes many sensors and is not affected by the skull or scalp in any way. Researchers can localize the neuronal activity to a particular sublobar region, often to a single gyrus or sulcus, when researchers combine MEG with the high-resolution anatomic pictures acquired by MRI. This allows us to pinpoint the precise location of the activity.
MEG helps patients with epilepsy locate the source of their epileptic discharges, and it does so without requiring the placement of electrodes within the patient's skull. When it is necessary to implant intracranial electrodes, magnetic resonance imaging (MEG) may assist in better planning the precise location of the implantation.
MEG technology gives patients undergoing neurosurgery access to helpful information for presurgical mapping in a method that does not involve any intrusive procedures. In addition, MEG technology makes it possible to combine structural and functional information, obtaining high spatial and temporal resolution in the process. This is a combination not presently offered by any other method of researching the brain.
The market for medical equipment in Japan is still significantly reliant on imports, particularly for more technologically advanced medical gadgets. As a result of Japan's rapidly aging demographic profile, there is likely to be a rise in the need for cutting-edge medical technology. Seniors in Japan who have been generally successful throughout their lives have increasingly lofty expectations for the quality of life they will enjoy in their old years. Therefore, there would be widespread acceptance of advances such as magnetoencephalography throughout the country, which would assist the expansion of regional markets.
The China market dominated the Asia Pacific Magnetoencephalography Market by Country in 2021; thereby, achieving a market value of $27,797.6 Thousands by 2028. The Japan market is registering a CAGR of 5% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 6.3% during (2022 - 2028).
Based on Application, the market is segmented into Clinical and Research. Based on Clinical Type, the market is segmented into Epilepsy, Dementia, Autism, Stroke, Multiple Sclerosis, Schizophrenia and Others. Based on End-use, the market is segmented into Hospitals, Academic & Research Institutes and Imaging centres. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Compumedics Limited, Ricoh Company, Ltd, FieldLine, Inc., MEGIN OY, CTF MEG Neuro Innovations, Inc. and Cerca Magnetics Limited
Scope of the Study
Market Segments Covered in the Report:
By Application
- Clinical
- Epilepsy
- Dementia
- Autism
- Stroke
- Multiple Sclerosis
- Schizophrenia
- Others
- Research
By End-use
- Hospitals
- Academic & Research Institutes
- Imaging centres
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Compumedics Limited
- Ricoh Company, Ltd
- FieldLine, Inc
- MEGIN OY
- CTF MEG Neuro Innovations, Inc
- Cerca Magnetics Limited
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Magnetoencephalography Market, by Application
1.4.2 Asia Pacific Magnetoencephalography Market, by End-use
1.4.3 Asia Pacific Magnetoencephalography Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Magnetoencephalography Market by Application
3.1 Asia Pacific Clinical Market by Country
3.2 Asia Pacific Magnetoencephalography Market by Clinical Type
3.2.1 Asia Pacific Epilepsy Market by Country
3.2.2 Asia Pacific Dementia Market by Country
3.2.3 Asia Pacific Autism Market by Country
3.2.4 Asia Pacific Stroke Market by Country
3.2.5 Asia Pacific Multiple Sclerosis Market by Country
3.2.6 Asia Pacific Schizophrenia Market by Country
3.2.7 Asia Pacific Others Market by Country
3.3 Asia Pacific Research Market by Country
Chapter 4. Asia Pacific Magnetoencephalography Market by End-use
4.1 Asia Pacific Hospitals Market by Country
4.2 Asia Pacific Academic & Research Institutes Market by Country
4.3 Asia Pacific Imaging centres Market by Country
Chapter 5. Asia Pacific Magnetoencephalography Market by Country
5.1 China Magnetoencephalography Market
5.1.1 China Magnetoencephalography Market by Application
5.1.1.1 China Magnetoencephalography Market by Clinical Type
5.1.2 China Magnetoencephalography Market by End-use
5.2 Japan Magnetoencephalography Market
5.2.1 Japan Magnetoencephalography Market by Application
5.2.1.1 Japan Magnetoencephalography Market by Clinical Type
5.2.2 Japan Magnetoencephalography Market by End-use
5.3 India Magnetoencephalography Market
5.3.1 India Magnetoencephalography Market by Application
5.3.1.1 India Magnetoencephalography Market by Clinical Type
5.3.2 India Magnetoencephalography Market by End-use
5.4 South Korea Magnetoencephalography Market
5.4.1 South Korea Magnetoencephalography Market by Application
5.4.1.1 South Korea Magnetoencephalography Market by Clinical Type
5.4.2 South Korea Magnetoencephalography Market by End-use
5.5 Singapore Magnetoencephalography Market
5.5.1 Singapore Magnetoencephalography Market by Application
5.5.1.1 Singapore Magnetoencephalography Market by Clinical Type
5.5.2 Singapore Magnetoencephalography Market by End-use
5.6 Malaysia Magnetoencephalography Market
5.6.1 Malaysia Magnetoencephalography Market by Application
5.6.1.1 Malaysia Magnetoencephalography Market by Clinical Type
5.6.2 Malaysia Magnetoencephalography Market by End-use
5.7 Rest of Asia Pacific Magnetoencephalography Market
5.7.1 Rest of Asia Pacific Magnetoencephalography Market by Application
5.7.1.1 Rest of Asia Pacific Magnetoencephalography Market by Clinical Type
5.7.2 Rest of Asia Pacific Magnetoencephalography Market by End-use
Chapter 6. Company Profiles
6.1 Compumedics Limited
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Approvals and Trials:
6.1.5.2 Partnerships, Collaborations and Agreements:
6.2 Ricoh Company, Ltd
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.3 FieldLine, Inc.
6.3.1 Company Overview
6.3.2 Recent strategies and developments:
6.3.2.1 Product Launches and Product Expansions:
6.4 MEGIN OY
6.4.1 Company Overview
6.5 CTF MEG Neuro Innovations, Inc.
6.5.1 Company Overview
6.6 Cerca Magnetics Limited
6.6.1 Company Overview
Companies Mentioned
- Compumedics Limited
- Ricoh Company, Ltd
- FieldLine, Inc.
- MEGIN OY
- CTF MEG Neuro Innovations, Inc.
- Cerca Magnetics Limited
Methodology
LOADING...
